← Back to Search

Telerehabilitation for Low Vision (BeST-AID Trial)

N/A
Waitlist Available
Led By Ava K Bittner, OD, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if remote video training and Bluetooth sensors can help people with low vision use magnifiers better. It aims to make it easier for patients who can't attend frequent in-office visits and to monitor their progress at home.

Who is the study for?
This trial is for adults with any level of vision loss from ocular disease who have just received new magnification devices. It's not suitable for those with substance abuse, significant hearing loss, major health issues affecting lifespan or participation, scheduling conflicts during the study period, cognitive impairments that affect communication and understanding, or need other types of low vision rehabilitation training.
What is being tested?
The trial is testing telerehabilitation—a way to train patients in using magnification devices via videoconferencing at home—against traditional in-office training. Participants will be randomly assigned to either home-based teletraining or additional office sessions after an initial office visit. The use of Bluetooth beacon sensors on devices will also be evaluated to monitor usage patterns.
What are the potential side effects?
Since this intervention involves non-invasive training and monitoring methods rather than medication or surgery, there are no direct medical side effects expected. However, participants may experience frustration or difficulty adapting to the technology used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Activity Inventory
Secondary study objectives
Geriatric Depression Scale (GDS)
Hospital Anxiety & Depression Scale
MNread
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Telerehabilitation with low vision providerExperimental Treatment1 Intervention
Group II: Telerehabilitation w/ low vision provider plus tele-extenderExperimental Treatment1 Intervention
Group III: Usual Care (active control)Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Vision Rehabilitation
2019
N/A
~210

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Low Vision (LV) include the use of magnification devices and telerehabilitation. Magnification devices, such as handheld magnifiers, work by enlarging text and objects, making them easier to see for individuals with reduced vision. Telerehabilitation involves remote delivery of low vision rehabilitation services, where patients receive training on how to use these devices effectively from the comfort of their homes. This approach is particularly important for LV patients as it addresses barriers like transportation and co-morbidities, ensuring continuous support and timely intervention to optimize visual function and improve quality of life.

Find a Location

Who is running the clinical trial?

Boston University Eye Associates, Inc. (study site)UNKNOWN
University of Nebraska Medical Center, Dept. of Ophthalmology (study site)UNKNOWN
University of California, Los AngelesLead Sponsor
1,559 Previous Clinical Trials
10,258,810 Total Patients Enrolled

Media Library

Low Vision Rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT04066075 — N/A
Low Vision Research Study Groups: Telerehabilitation with low vision provider, Telerehabilitation w/ low vision provider plus tele-extender, Usual Care (active control)
Low Vision Clinical Trial 2023: Low Vision Rehabilitation Highlights & Side Effects. Trial Name: NCT04066075 — N/A
Low Vision Rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04066075 — N/A
~10 spots leftby Oct 2025